SlideShare a Scribd company logo
The dynamics of drug absorption and
distribution
Presented by : Tailor Himani Rajubhai
Department of Pharmacology
L. M. College Of Pharmacy
Physicochemical factors in transfer of drugs
across membranes:
• The determining characteristics of the drug are
its molecular size and shape, degree of
ionization, relative lipid solubility of its ionized
and unionized forms, and its binding to tissue
proteins.
• Despite of structural differences the diffusion
and transport of drugs across these various
boundaries have many common characteristics,
since drugs in general pass through cells rather
than between them. The plasma membrane
thus represents the common barrier.
• Drug molecules can cross cell membrane by:
passive diffusion; protein-mediated transport (
facilitated and active transport)
Biological Membrane
• Bilayer of amphipathic lipid
 hydrocarbon chains oriented
inward to form a continues
hydrophilic tail and hydrophilic
head oriented outward.
• Membrane proteins embedded
in the bilayer serve as receptors,
ion channel or transporters to
elicit electrical or chemical
signaling pathways and provide
selective targets for drug action.
-
Passage of drug across cell membrane
• The cell membrane acts as a biological barrier. The following are the
processes by which a drug can cross biological membrane
1. Passive transport
-Diffusion(simple)
-Filtration
-osmosis
2. Specialized transport
-Active transport
*Primary active transport(direct active transport)
*secondary active transport(co-transport)
-Endocytosis
*Phagocytosis
*pinocytosis
*Receptor mediated endocytosis
A. Passive membrane transport
• This transport is energy independent and no utilization of ATPs.
a. Diffusion (simple)
• Diffusion is the net movement of drug molecules from an area of high concentration to an area with lower
concentration.
• The difference of concentration between the two areas is termed as the concentration gradient, and
diffusion will continue until this gradient has been eliminated.
• Diffusion across the cell membrane depends on concentration gradient and lipid solubility. Lipid solubility
depends on ionization. Un-ionized drugs are more lipid soluble and are better absorbed (more reabsorbed
in the kidneys and less excreted).
• Ionized drugs are less lipid soluble and are less absorbed (less reabsorbed in kidneys and more excreted).
Ionization depends on pH of drug and pH of the medium (surrounding fluid).
• If the pH is the same the drug remain unionized and become more lipid soluble and absorbed better. Acidic
drugs like aspirin, barbiturates, etc. are better absorbed from the stomach. Alkaline drugs like morphine,
atropine, and chloroquine are better absorbed from the small intestine. If pH is opposite-> drug is ionized->
less lipid soluble-> less absorption (e.g. alkaline drugs are poorly absorbed in the stomach). .
b. Filtration and Osmosis
• This can be accelerated if hydrodynamic flow of the solvent is
occurring under hydrostatic or osmotic pressure gradient. E.g: across
most capillaries including glomeruli.
Filtration- is movement of drugs through aqueous pores in the
membrane or through paracellular spaces.
• Lipid insoluble drugs can cross the biological membrane by filtration if
the molecular size is smaller than that of the diameter of pores.
Osmosis-Osmosis is the movement of water molecule through the cell
membrane (semi permeable membrane) from the region of higher
water concentration to the region of less water concentration is called
osmosis
Weak electrolytes and influence of pH
• Most drugs are- weak acids or bases.
• Non-ionized molecules- lipid soluble- diffuse across membrane.
• Transmembrane distribution of weak electrolyte is usually
determined by its pKa and pH gradient. pKa is numerically equal to
the pH at which the drug is 50% ionized.
• Henderson- hasselbalch equation: for weak acid,
• pH= pKa+ log [A-]/ [HA] where, A- is ionized and HA is unionized drug.
If concentration of both is equal then log 1= 0 hence pH= pKa.
• If pH is increased by scale 1 scale then log [A-]/ [HA] =1 or [A-]/ [HA]
=10. Similarly if reduced by 1 then [A-]/ [HA] = 1/10.
B. Specialized transport
a. Facilitated diffusion(solute carrier SLC transporters)-It is the movement
of drug molecules across the cell membrane via special transport proteins
that are present within the cellular membrane.
• Many large molecules, such as glucose, are insoluble in lipids and too large
to pass through the membrane pores. Therefore, it will bind with its specific
carrier proteins, and moved through the cellular membrane.
• Active transport- In active transport, the drug molecule penetrates in
the lipid bilayer membrane from lower concentration to the higher
concentration of solutes against the concentration gradient by utilizing
energy (ATP) and with the help of carrier proteins.
• There are two types
- Primary active transport and
-secondary active transport.
C . Endocytosis
Absorption
• Absorption is the movement or transfer of a drug from it’s site of
application into the blood circulation.
• Not only the fraction of administered dose that gets absorbed, but also the
rate of absorption is important
• When a drug is administered intravenously, absorption is not required
because the drug is transferred from the administration device directly
into the bloodstream. In the case of intravenous administration, the entire
dose of the drug is available to move to the sites of drug action.
• Drug administration by other routes may result in only partial absorption
and thus, lower bioavailability.
• Passage of drug across cell membrane- The cell membrane acts as a
biological barrier.
Factors affecting absorption
1. Lipid solubility- Absorption of drugs depends on lipid solubility.
Absorption is more if the drug is lipid soluble. Lipid solubility depends
on ionization. Un-ionized drugs are more lipid soluble and are better
absorbed. Ionized drugs are less lipid soluble and are less absorbed.
2. Molecular size- Smaller the molecular size of the drug rapid is the
absorption.
3. Particle size - Particle may be composed either of a single molecule
or more than hundred molecules. Larger is the particle size, slower will
be the diffusion and absorption and vice versa.
4. Degree of ionization- Un-ionized drugs are more lipid soluble and
are better absorbed (more reabsorbed in the kidneys and less
excreted). Ionized drugs are less lipid soluble and are less absorbed
(less reabsorbed in kidneys and more excreted). Ionization depends on
pH of drug and pH of the medium (surrounding fluid). If the pH is the
same the drug remain unionized and become lipid soluble and
absorbed better. (e.g. acidic drugs like aspirin, barbiturates, etc. are
better absorbed from the stomach. Weakly alkaline drugs like
morphine, atropine, chloroquine are better absorbed from the small
intestine.
5. Physical forms- Drugs may exist as solids, liquids or gases. Gases are
rapidly absorbed than the liquids, while liquids are rapidly absorbed
than the solids. Thus the drugs in syrup or suspension form are rapidly
absorbed than the tablets or capsules. Volatile general anaesthetics
absorbed rapidly through the pulmonary route.
.
6. Chemical nature-Chemical nature is responsible for the selection of the
route of drug administration. Examples- Heparin is a drug with large
molecular weight, and is cannot be given orally, insulin is degraded if given
orally, benzyl penicillin also get degraded if given orally. Hence these drugs
should be administered parenterally to avoid the inactivation
7. Dosage forms- Dosage forms affect the rate and extent of absorption.
Example – nitroglycerin when given by sublingual route disintegrates rapidly
but stays for a shorter duration. When it is given orally, it disintegrates slowly
and stays for longer duration.
8. Concentration - If the drug concentration increases the drug absorption
across the cell membrane also increases.
9. Area of absorptive surface- Most of the drugs are given orally because of
the large area of absorptive surface, so that greater absorption occurs.
Organophosphate compounds (insecticides) are highly lipid soluble and
poisoning can occur even by absorption through skin.
10.Vascularity - If the vascularity (blood supply) is more, the drug absorption
also increases. In shock, the blood supply decreases, hence the drug
absorption decreases. During IM inj massage increases vascular supply and
drug absorption
11. pH – Acidic pH favours the absorption of acidic drugs and basic pH
favours the absorption of basic drugs.
12. Presence of other substances- Food can increase or decrease the drug
absorption. Examples- Atorvastatin is better absorbed when taken with the
food. Milk decreases the absorption of iron. Vitamin C enhances the
absorption of iron. Milk decreases the absorption of tetracycline.
13. GI motility- The drug absorption gets altered in diarrhoea or
constipation.
14-Diseases- In diarrhoea drug absorption decreases, malabsorptive
syndrome- decreases drug absorption, in achlorhydria – decreases the
absorption of acidic drugs.
DRUG DISTRIBUTION
• Once in the blood, drugs are simultaneously distributed throughout
the body and eliminated. Typically, distribution is much more rapid
than elimination, is accomplished via the circulation, and is influenced
by regional blood flow.
Volume of Distribution (Vd)
Definition: Apparent Volume of distribution is defined as the volume
that would accommodate all the drugs in the body, if the concentration
was the same as in plasma,
Expressed as: in Liters
Vd =
Dose administered IV
Plasma concentration
A. Compartments
1. Central Compartment
• The central compartment includes the well-perfused organs and
tissues
• (heart, blood, liver, brain and kidney) with which drug equilibrates
rapidly.
2. Peripheral Compartment(s)
• The peripheral compartment(s) include(s) those organs (e.g., adipose
and skeletal muscle) which are less well-perfused, and with which
drug therefore equilibrates more slowly.
• Redistribution from one compartment to another often alters the
duration of effect at the target tissue.
• For example, thiopental, a highly lipid-soluble drug, induces
anaesthesia within seconds because of rapid equilibration between
blood and brain.
• Despite the fact that the drug is slowly metabolized, however, the
duration of anesthesia is short because of drug redistribution into
adipose tissue, which can act as a storage site, or drug reservoir.
3. Special compartment
• Several special compartments deserve mention.
• Entry of drug into the cerebrospinal fluid (CSF) and central nervous
system (CNS) is restricted by the structure of the capillaries and
pericapillary glial cells (the choroid plexus is an exception).
• The blood-brain barrier limits the success of antibiotics, anticancer
drugs and other agents used to treat CNS diseases.
• Drugs also have relatively poor access to pericardial fluid, bronchial
secretions and fluid in the middle ear, thus making the treatment of
infections in these regions difficult.
B. Protein Binding
• Many drugs bind to plasma proteins.
Weak acids and neutral drugs bind particularly to albumin,
while basic drugs tend to bind to alpha-1-acid glycoprotein
(orosomucoid).
Effects on drug distribution
• Only that fraction of the plasma drug concentration which is freely
circulating (i.e., unbound) can penetrate cell membranes.
• Protein binding thus decreases the net transfer of drug across
membranes.
• Drug binding to plasma proteins is generally weak and rapidly
reversible, however, so that protein-bound drug can be considered to
be in a temporary storage compartment.
• The protein concentration of extravascular fluids (e.g., CSF, lymph,
synovial fluid) is very low.
• The extent of protein binding must be considered in interpreting
"blood levels" of drugs.
Placental Transfer of Drugs
• The transfer of drugs across the placenta is of critical importance
because drugs may cause anomalies in the developing fetus.
• Administered immediately before delivery, as is often the case with
the use of tocolytics in the treatment of preterm labor, they also may
have adverse effects on the neonate.
• As in the brain, P-gp and other export transporters are present in the
placenta and function to limit fetal exposure to potentially toxic
agents.
References:
• http://downloads.lww.com/wolterskluwer_vitalstream_com/sample-
content/9780781773485_Sakai/samples/Sakai_Ch03.pdf
• “The pharmacological basis of therapeutics “by Goodman & Gilman,
tenth edition.
• “Essential of medical pharmacology” by KD Tripathi, seventh edition.
•THANK YOU

More Related Content

What's hot

Screening model for asthma COPD
Screening model for asthma COPDScreening model for asthma COPD
Screening model for asthma COPD
Jaineel Dharod
 
Preclinical screening models of copd
Preclinical screening models of copdPreclinical screening models of copd
Preclinical screening models of copd
Prajitha p
 
Genetic variations in gpcr
Genetic variations in gpcrGenetic variations in gpcr
Genetic variations in gpcr
Meenakshi Gupta
 
screening methods for Antiepileptic activity
screening methods for Antiepileptic activityscreening methods for Antiepileptic activity
screening methods for Antiepileptic activitySravanthi Shetty
 
Polymorphism Affecting Drug Metabolism
Polymorphism Affecting Drug MetabolismPolymorphism Affecting Drug Metabolism
Genetic variation in drug transporters
Genetic variation in drug transportersGenetic variation in drug transporters
Genetic variation in drug transporters
Deepak Kumar
 
Preclinical screening of anti fertility agents
Preclinical screening of anti fertility agentsPreclinical screening of anti fertility agents
Preclinical screening of anti fertility agents
Naveen K L
 
Screening Models of Anti-Atherosclerosis
Screening Models of Anti-AtherosclerosisScreening Models of Anti-Atherosclerosis
Screening of Diuretics M.PHARM PHARMACOLOGY.
Screening of Diuretics M.PHARM PHARMACOLOGY.Screening of Diuretics M.PHARM PHARMACOLOGY.
Screening of Diuretics M.PHARM PHARMACOLOGY.
S.G.S.S. COLLEGE OF PHARMACY, MANUR
 
Screening models of antiepileptic and nootropic drugs
Screening models of antiepileptic and nootropic drugsScreening models of antiepileptic and nootropic drugs
Screening models of antiepileptic and nootropic drugs
HimikaRathi
 
Preclinical screening methods of cns stimulants
Preclinical screening methods of cns stimulantsPreclinical screening methods of cns stimulants
Preclinical screening methods of cns stimulants
Rashmi116
 
Presentation on neurotransmitter’s acetylcholine and adrenaline converted
Presentation on neurotransmitter’s acetylcholine and adrenaline convertedPresentation on neurotransmitter’s acetylcholine and adrenaline converted
Presentation on neurotransmitter’s acetylcholine and adrenaline converted
B V V S Hanagal Shri Kumareshwar College of Pharmacy, Bagalkote
 
Seminar on histamine
Seminar on histamineSeminar on histamine
Seminar on histamine
kavyakaparthi1
 
Quantitative aspects of drug receptor interaction
Quantitative aspects of drug receptor interactionQuantitative aspects of drug receptor interaction
Quantitative aspects of drug receptor interaction
DrSahilKumar
 
Concept of non linear and linear pharmacokinetic model
Concept of non linear and linear pharmacokinetic modelConcept of non linear and linear pharmacokinetic model
Concept of non linear and linear pharmacokinetic model
University Institute of Pharmaceutical Sciences
 
Suhas (chronopharmacology of diabetes)
Suhas (chronopharmacology of diabetes)Suhas (chronopharmacology of diabetes)
Suhas (chronopharmacology of diabetes)
suhaspatil114
 
Hepatoprotective screening methods
Hepatoprotective screening methodsHepatoprotective screening methods
Hepatoprotective screening methods
ShobhiniChandel
 
Preclinical screening of antiallergics
Preclinical screening of antiallergicsPreclinical screening of antiallergics
Preclinical screening of antiallergics
Prajitha p
 
Screening of antiparkinson agent
Screening of antiparkinson agentScreening of antiparkinson agent
Screening of antiparkinson agent
SONALPANDE5
 
PRINCIPLE AND APPLICATIONS OF CELL VIABILITY, GLUCOSE UPTAKE AND CALCIUM UPT...
PRINCIPLE AND APPLICATIONS OF CELL VIABILITY, GLUCOSE UPTAKE  AND CALCIUM UPT...PRINCIPLE AND APPLICATIONS OF CELL VIABILITY, GLUCOSE UPTAKE  AND CALCIUM UPT...
PRINCIPLE AND APPLICATIONS OF CELL VIABILITY, GLUCOSE UPTAKE AND CALCIUM UPT...
Raghavendra institute of pharmaceutical education and research .
 

What's hot (20)

Screening model for asthma COPD
Screening model for asthma COPDScreening model for asthma COPD
Screening model for asthma COPD
 
Preclinical screening models of copd
Preclinical screening models of copdPreclinical screening models of copd
Preclinical screening models of copd
 
Genetic variations in gpcr
Genetic variations in gpcrGenetic variations in gpcr
Genetic variations in gpcr
 
screening methods for Antiepileptic activity
screening methods for Antiepileptic activityscreening methods for Antiepileptic activity
screening methods for Antiepileptic activity
 
Polymorphism Affecting Drug Metabolism
Polymorphism Affecting Drug MetabolismPolymorphism Affecting Drug Metabolism
Polymorphism Affecting Drug Metabolism
 
Genetic variation in drug transporters
Genetic variation in drug transportersGenetic variation in drug transporters
Genetic variation in drug transporters
 
Preclinical screening of anti fertility agents
Preclinical screening of anti fertility agentsPreclinical screening of anti fertility agents
Preclinical screening of anti fertility agents
 
Screening Models of Anti-Atherosclerosis
Screening Models of Anti-AtherosclerosisScreening Models of Anti-Atherosclerosis
Screening Models of Anti-Atherosclerosis
 
Screening of Diuretics M.PHARM PHARMACOLOGY.
Screening of Diuretics M.PHARM PHARMACOLOGY.Screening of Diuretics M.PHARM PHARMACOLOGY.
Screening of Diuretics M.PHARM PHARMACOLOGY.
 
Screening models of antiepileptic and nootropic drugs
Screening models of antiepileptic and nootropic drugsScreening models of antiepileptic and nootropic drugs
Screening models of antiepileptic and nootropic drugs
 
Preclinical screening methods of cns stimulants
Preclinical screening methods of cns stimulantsPreclinical screening methods of cns stimulants
Preclinical screening methods of cns stimulants
 
Presentation on neurotransmitter’s acetylcholine and adrenaline converted
Presentation on neurotransmitter’s acetylcholine and adrenaline convertedPresentation on neurotransmitter’s acetylcholine and adrenaline converted
Presentation on neurotransmitter’s acetylcholine and adrenaline converted
 
Seminar on histamine
Seminar on histamineSeminar on histamine
Seminar on histamine
 
Quantitative aspects of drug receptor interaction
Quantitative aspects of drug receptor interactionQuantitative aspects of drug receptor interaction
Quantitative aspects of drug receptor interaction
 
Concept of non linear and linear pharmacokinetic model
Concept of non linear and linear pharmacokinetic modelConcept of non linear and linear pharmacokinetic model
Concept of non linear and linear pharmacokinetic model
 
Suhas (chronopharmacology of diabetes)
Suhas (chronopharmacology of diabetes)Suhas (chronopharmacology of diabetes)
Suhas (chronopharmacology of diabetes)
 
Hepatoprotective screening methods
Hepatoprotective screening methodsHepatoprotective screening methods
Hepatoprotective screening methods
 
Preclinical screening of antiallergics
Preclinical screening of antiallergicsPreclinical screening of antiallergics
Preclinical screening of antiallergics
 
Screening of antiparkinson agent
Screening of antiparkinson agentScreening of antiparkinson agent
Screening of antiparkinson agent
 
PRINCIPLE AND APPLICATIONS OF CELL VIABILITY, GLUCOSE UPTAKE AND CALCIUM UPT...
PRINCIPLE AND APPLICATIONS OF CELL VIABILITY, GLUCOSE UPTAKE  AND CALCIUM UPT...PRINCIPLE AND APPLICATIONS OF CELL VIABILITY, GLUCOSE UPTAKE  AND CALCIUM UPT...
PRINCIPLE AND APPLICATIONS OF CELL VIABILITY, GLUCOSE UPTAKE AND CALCIUM UPT...
 

Similar to The dynamics of drug ABSORPTION and DISTRIBUTION

Pharmacokinetic and pharmacodynamic
Pharmacokinetic and pharmacodynamicPharmacokinetic and pharmacodynamic
Pharmacokinetic and pharmacodynamic
Mohd Khaffizullah Mohd Rajali
 
Pharmacokinetics.pptx
Pharmacokinetics.pptxPharmacokinetics.pptx
Pharmacokinetics.pptx
Dr.Arka Mondal
 
Basics of Pharmacokinetic.pptx
Basics of Pharmacokinetic.pptxBasics of Pharmacokinetic.pptx
Basics of Pharmacokinetic.pptx
rubinawatangi1
 
PHARMACOKINETIC
PHARMACOKINETICPHARMACOKINETIC
PHARMACOKINETIC
SanjogBam
 
Pharmacokinetics class 2
Pharmacokinetics   class 2Pharmacokinetics   class 2
Pharmacokinetics class 2
candyshridhar24
 
P'Kinetics - I.pptx
P'Kinetics - I.pptxP'Kinetics - I.pptx
P'Kinetics - I.pptx
MsSapnaSapna
 
PHARMACODYNAMIC & PHARMACOKINETIC.pptx
PHARMACODYNAMIC & PHARMACOKINETIC.pptxPHARMACODYNAMIC & PHARMACOKINETIC.pptx
PHARMACODYNAMIC & PHARMACOKINETIC.pptx
Richa
 
Module 2 pharmacokinetics and drug metabolism
Module 2  pharmacokinetics and drug metabolismModule 2  pharmacokinetics and drug metabolism
Module 2 pharmacokinetics and drug metabolismjulialoiko
 
Pharmacokinetics and drug disposition
Pharmacokinetics and drug dispositionPharmacokinetics and drug disposition
Pharmacokinetics and drug disposition
Sachin Kumar
 
PHARMACOKINETICS & PHARMACDINEMICS.pptx
PHARMACOKINETICS & PHARMACDINEMICS.pptxPHARMACOKINETICS & PHARMACDINEMICS.pptx
Pharmacokinetics adme
Pharmacokinetics admePharmacokinetics adme
Pharmacokinetics adme
Deepa Urolagin
 
PHARMACOKINETICS.pptx
PHARMACOKINETICS.pptxPHARMACOKINETICS.pptx
PHARMACOKINETICS.pptx
anshikabhatnagar1299
 
Drug Pharmacokinetics
Drug Pharmacokinetics Drug Pharmacokinetics
Drug Pharmacokinetics
A M O L D E O R E
 
Pharmacokinetics: An overiew
Pharmacokinetics: An overiewPharmacokinetics: An overiew
Pharmacokinetics: An overiew
A M O L D E O R E
 
4_2017_10_19!10_00_11_AM.pptx
4_2017_10_19!10_00_11_AM.pptx4_2017_10_19!10_00_11_AM.pptx
4_2017_10_19!10_00_11_AM.pptx
ssuser497f37
 
Dental Pharmacology -Pharmacokinetics
Dental Pharmacology -PharmacokineticsDental Pharmacology -Pharmacokinetics
Dental Pharmacology -Pharmacokinetics
Taha Hussein Kadi
 
Pharmacokinetics,
Pharmacokinetics, Pharmacokinetics,
Pharmacokinetics,
Dr. Rupendra Bharti
 
Advanced practice preparation pharmacokinetics
Advanced practice preparation pharmacokineticsAdvanced practice preparation pharmacokinetics
Advanced practice preparation pharmacokineticsUniversity of Miami
 
Advanced practice preparation pharmacokinetics
Advanced practice preparation pharmacokineticsAdvanced practice preparation pharmacokinetics
Advanced practice preparation pharmacokineticsUniversity of Miami
 

Similar to The dynamics of drug ABSORPTION and DISTRIBUTION (20)

Pharmacokinetic and pharmacodynamic
Pharmacokinetic and pharmacodynamicPharmacokinetic and pharmacodynamic
Pharmacokinetic and pharmacodynamic
 
Pharmacokinetics.pptx
Pharmacokinetics.pptxPharmacokinetics.pptx
Pharmacokinetics.pptx
 
Basics of Pharmacokinetic.pptx
Basics of Pharmacokinetic.pptxBasics of Pharmacokinetic.pptx
Basics of Pharmacokinetic.pptx
 
PHARMACOKINETIC
PHARMACOKINETICPHARMACOKINETIC
PHARMACOKINETIC
 
Pharmacokinetics class 2
Pharmacokinetics   class 2Pharmacokinetics   class 2
Pharmacokinetics class 2
 
P'Kinetics - I.pptx
P'Kinetics - I.pptxP'Kinetics - I.pptx
P'Kinetics - I.pptx
 
PHARMACODYNAMIC & PHARMACOKINETIC.pptx
PHARMACODYNAMIC & PHARMACOKINETIC.pptxPHARMACODYNAMIC & PHARMACOKINETIC.pptx
PHARMACODYNAMIC & PHARMACOKINETIC.pptx
 
Module 2 pharmacokinetics and drug metabolism
Module 2  pharmacokinetics and drug metabolismModule 2  pharmacokinetics and drug metabolism
Module 2 pharmacokinetics and drug metabolism
 
Pharmacokinetics and drug disposition
Pharmacokinetics and drug dispositionPharmacokinetics and drug disposition
Pharmacokinetics and drug disposition
 
PHARMACOKINETICS & PHARMACDINEMICS.pptx
PHARMACOKINETICS & PHARMACDINEMICS.pptxPHARMACOKINETICS & PHARMACDINEMICS.pptx
PHARMACOKINETICS & PHARMACDINEMICS.pptx
 
Pharmacokinetics adme
Pharmacokinetics admePharmacokinetics adme
Pharmacokinetics adme
 
PHARMACOKINETICS.pptx
PHARMACOKINETICS.pptxPHARMACOKINETICS.pptx
PHARMACOKINETICS.pptx
 
Drug Pharmacokinetics
Drug Pharmacokinetics Drug Pharmacokinetics
Drug Pharmacokinetics
 
Pharmacokinetics
PharmacokineticsPharmacokinetics
Pharmacokinetics
 
Pharmacokinetics: An overiew
Pharmacokinetics: An overiewPharmacokinetics: An overiew
Pharmacokinetics: An overiew
 
4_2017_10_19!10_00_11_AM.pptx
4_2017_10_19!10_00_11_AM.pptx4_2017_10_19!10_00_11_AM.pptx
4_2017_10_19!10_00_11_AM.pptx
 
Dental Pharmacology -Pharmacokinetics
Dental Pharmacology -PharmacokineticsDental Pharmacology -Pharmacokinetics
Dental Pharmacology -Pharmacokinetics
 
Pharmacokinetics,
Pharmacokinetics, Pharmacokinetics,
Pharmacokinetics,
 
Advanced practice preparation pharmacokinetics
Advanced practice preparation pharmacokineticsAdvanced practice preparation pharmacokinetics
Advanced practice preparation pharmacokinetics
 
Advanced practice preparation pharmacokinetics
Advanced practice preparation pharmacokineticsAdvanced practice preparation pharmacokinetics
Advanced practice preparation pharmacokinetics
 

Recently uploaded

1.4 modern child centered education - mahatma gandhi-2.pptx
1.4 modern child centered education - mahatma gandhi-2.pptx1.4 modern child centered education - mahatma gandhi-2.pptx
1.4 modern child centered education - mahatma gandhi-2.pptx
JosvitaDsouza2
 
Model Attribute Check Company Auto Property
Model Attribute  Check Company Auto PropertyModel Attribute  Check Company Auto Property
Model Attribute Check Company Auto Property
Celine George
 
Introduction to AI for Nonprofits with Tapp Network
Introduction to AI for Nonprofits with Tapp NetworkIntroduction to AI for Nonprofits with Tapp Network
Introduction to AI for Nonprofits with Tapp Network
TechSoup
 
The basics of sentences session 5pptx.pptx
The basics of sentences session 5pptx.pptxThe basics of sentences session 5pptx.pptx
The basics of sentences session 5pptx.pptx
heathfieldcps1
 
Operation Blue Star - Saka Neela Tara
Operation Blue Star   -  Saka Neela TaraOperation Blue Star   -  Saka Neela Tara
Operation Blue Star - Saka Neela Tara
Balvir Singh
 
Overview on Edible Vaccine: Pros & Cons with Mechanism
Overview on Edible Vaccine: Pros & Cons with MechanismOverview on Edible Vaccine: Pros & Cons with Mechanism
Overview on Edible Vaccine: Pros & Cons with Mechanism
DeeptiGupta154
 
CACJapan - GROUP Presentation 1- Wk 4.pdf
CACJapan - GROUP Presentation 1- Wk 4.pdfCACJapan - GROUP Presentation 1- Wk 4.pdf
CACJapan - GROUP Presentation 1- Wk 4.pdf
camakaiclarkmusic
 
"Protectable subject matters, Protection in biotechnology, Protection of othe...
"Protectable subject matters, Protection in biotechnology, Protection of othe..."Protectable subject matters, Protection in biotechnology, Protection of othe...
"Protectable subject matters, Protection in biotechnology, Protection of othe...
SACHIN R KONDAGURI
 
Mule 4.6 & Java 17 Upgrade | MuleSoft Mysore Meetup #46
Mule 4.6 & Java 17 Upgrade | MuleSoft Mysore Meetup #46Mule 4.6 & Java 17 Upgrade | MuleSoft Mysore Meetup #46
Mule 4.6 & Java 17 Upgrade | MuleSoft Mysore Meetup #46
MysoreMuleSoftMeetup
 
Advantages and Disadvantages of CMS from an SEO Perspective
Advantages and Disadvantages of CMS from an SEO PerspectiveAdvantages and Disadvantages of CMS from an SEO Perspective
Advantages and Disadvantages of CMS from an SEO Perspective
Krisztián Száraz
 
A Strategic Approach: GenAI in Education
A Strategic Approach: GenAI in EducationA Strategic Approach: GenAI in Education
A Strategic Approach: GenAI in Education
Peter Windle
 
Chapter 3 - Islamic Banking Products and Services.pptx
Chapter 3 - Islamic Banking Products and Services.pptxChapter 3 - Islamic Banking Products and Services.pptx
Chapter 3 - Islamic Banking Products and Services.pptx
Mohd Adib Abd Muin, Senior Lecturer at Universiti Utara Malaysia
 
June 3, 2024 Anti-Semitism Letter Sent to MIT President Kornbluth and MIT Cor...
June 3, 2024 Anti-Semitism Letter Sent to MIT President Kornbluth and MIT Cor...June 3, 2024 Anti-Semitism Letter Sent to MIT President Kornbluth and MIT Cor...
June 3, 2024 Anti-Semitism Letter Sent to MIT President Kornbluth and MIT Cor...
Levi Shapiro
 
Acetabularia Information For Class 9 .docx
Acetabularia Information For Class 9  .docxAcetabularia Information For Class 9  .docx
Acetabularia Information For Class 9 .docx
vaibhavrinwa19
 
How libraries can support authors with open access requirements for UKRI fund...
How libraries can support authors with open access requirements for UKRI fund...How libraries can support authors with open access requirements for UKRI fund...
How libraries can support authors with open access requirements for UKRI fund...
Jisc
 
Executive Directors Chat Leveraging AI for Diversity, Equity, and Inclusion
Executive Directors Chat  Leveraging AI for Diversity, Equity, and InclusionExecutive Directors Chat  Leveraging AI for Diversity, Equity, and Inclusion
Executive Directors Chat Leveraging AI for Diversity, Equity, and Inclusion
TechSoup
 
2024.06.01 Introducing a competency framework for languag learning materials ...
2024.06.01 Introducing a competency framework for languag learning materials ...2024.06.01 Introducing a competency framework for languag learning materials ...
2024.06.01 Introducing a competency framework for languag learning materials ...
Sandy Millin
 
BÀI TẬP BỔ TRỢ TIẾNG ANH GLOBAL SUCCESS LỚP 3 - CẢ NĂM (CÓ FILE NGHE VÀ ĐÁP Á...
BÀI TẬP BỔ TRỢ TIẾNG ANH GLOBAL SUCCESS LỚP 3 - CẢ NĂM (CÓ FILE NGHE VÀ ĐÁP Á...BÀI TẬP BỔ TRỢ TIẾNG ANH GLOBAL SUCCESS LỚP 3 - CẢ NĂM (CÓ FILE NGHE VÀ ĐÁP Á...
BÀI TẬP BỔ TRỢ TIẾNG ANH GLOBAL SUCCESS LỚP 3 - CẢ NĂM (CÓ FILE NGHE VÀ ĐÁP Á...
Nguyen Thanh Tu Collection
 
Best Digital Marketing Institute In NOIDA
Best Digital Marketing Institute In NOIDABest Digital Marketing Institute In NOIDA
Best Digital Marketing Institute In NOIDA
deeptiverma2406
 
JEE1_This_section_contains_FOUR_ questions
JEE1_This_section_contains_FOUR_ questionsJEE1_This_section_contains_FOUR_ questions
JEE1_This_section_contains_FOUR_ questions
ShivajiThube2
 

Recently uploaded (20)

1.4 modern child centered education - mahatma gandhi-2.pptx
1.4 modern child centered education - mahatma gandhi-2.pptx1.4 modern child centered education - mahatma gandhi-2.pptx
1.4 modern child centered education - mahatma gandhi-2.pptx
 
Model Attribute Check Company Auto Property
Model Attribute  Check Company Auto PropertyModel Attribute  Check Company Auto Property
Model Attribute Check Company Auto Property
 
Introduction to AI for Nonprofits with Tapp Network
Introduction to AI for Nonprofits with Tapp NetworkIntroduction to AI for Nonprofits with Tapp Network
Introduction to AI for Nonprofits with Tapp Network
 
The basics of sentences session 5pptx.pptx
The basics of sentences session 5pptx.pptxThe basics of sentences session 5pptx.pptx
The basics of sentences session 5pptx.pptx
 
Operation Blue Star - Saka Neela Tara
Operation Blue Star   -  Saka Neela TaraOperation Blue Star   -  Saka Neela Tara
Operation Blue Star - Saka Neela Tara
 
Overview on Edible Vaccine: Pros & Cons with Mechanism
Overview on Edible Vaccine: Pros & Cons with MechanismOverview on Edible Vaccine: Pros & Cons with Mechanism
Overview on Edible Vaccine: Pros & Cons with Mechanism
 
CACJapan - GROUP Presentation 1- Wk 4.pdf
CACJapan - GROUP Presentation 1- Wk 4.pdfCACJapan - GROUP Presentation 1- Wk 4.pdf
CACJapan - GROUP Presentation 1- Wk 4.pdf
 
"Protectable subject matters, Protection in biotechnology, Protection of othe...
"Protectable subject matters, Protection in biotechnology, Protection of othe..."Protectable subject matters, Protection in biotechnology, Protection of othe...
"Protectable subject matters, Protection in biotechnology, Protection of othe...
 
Mule 4.6 & Java 17 Upgrade | MuleSoft Mysore Meetup #46
Mule 4.6 & Java 17 Upgrade | MuleSoft Mysore Meetup #46Mule 4.6 & Java 17 Upgrade | MuleSoft Mysore Meetup #46
Mule 4.6 & Java 17 Upgrade | MuleSoft Mysore Meetup #46
 
Advantages and Disadvantages of CMS from an SEO Perspective
Advantages and Disadvantages of CMS from an SEO PerspectiveAdvantages and Disadvantages of CMS from an SEO Perspective
Advantages and Disadvantages of CMS from an SEO Perspective
 
A Strategic Approach: GenAI in Education
A Strategic Approach: GenAI in EducationA Strategic Approach: GenAI in Education
A Strategic Approach: GenAI in Education
 
Chapter 3 - Islamic Banking Products and Services.pptx
Chapter 3 - Islamic Banking Products and Services.pptxChapter 3 - Islamic Banking Products and Services.pptx
Chapter 3 - Islamic Banking Products and Services.pptx
 
June 3, 2024 Anti-Semitism Letter Sent to MIT President Kornbluth and MIT Cor...
June 3, 2024 Anti-Semitism Letter Sent to MIT President Kornbluth and MIT Cor...June 3, 2024 Anti-Semitism Letter Sent to MIT President Kornbluth and MIT Cor...
June 3, 2024 Anti-Semitism Letter Sent to MIT President Kornbluth and MIT Cor...
 
Acetabularia Information For Class 9 .docx
Acetabularia Information For Class 9  .docxAcetabularia Information For Class 9  .docx
Acetabularia Information For Class 9 .docx
 
How libraries can support authors with open access requirements for UKRI fund...
How libraries can support authors with open access requirements for UKRI fund...How libraries can support authors with open access requirements for UKRI fund...
How libraries can support authors with open access requirements for UKRI fund...
 
Executive Directors Chat Leveraging AI for Diversity, Equity, and Inclusion
Executive Directors Chat  Leveraging AI for Diversity, Equity, and InclusionExecutive Directors Chat  Leveraging AI for Diversity, Equity, and Inclusion
Executive Directors Chat Leveraging AI for Diversity, Equity, and Inclusion
 
2024.06.01 Introducing a competency framework for languag learning materials ...
2024.06.01 Introducing a competency framework for languag learning materials ...2024.06.01 Introducing a competency framework for languag learning materials ...
2024.06.01 Introducing a competency framework for languag learning materials ...
 
BÀI TẬP BỔ TRỢ TIẾNG ANH GLOBAL SUCCESS LỚP 3 - CẢ NĂM (CÓ FILE NGHE VÀ ĐÁP Á...
BÀI TẬP BỔ TRỢ TIẾNG ANH GLOBAL SUCCESS LỚP 3 - CẢ NĂM (CÓ FILE NGHE VÀ ĐÁP Á...BÀI TẬP BỔ TRỢ TIẾNG ANH GLOBAL SUCCESS LỚP 3 - CẢ NĂM (CÓ FILE NGHE VÀ ĐÁP Á...
BÀI TẬP BỔ TRỢ TIẾNG ANH GLOBAL SUCCESS LỚP 3 - CẢ NĂM (CÓ FILE NGHE VÀ ĐÁP Á...
 
Best Digital Marketing Institute In NOIDA
Best Digital Marketing Institute In NOIDABest Digital Marketing Institute In NOIDA
Best Digital Marketing Institute In NOIDA
 
JEE1_This_section_contains_FOUR_ questions
JEE1_This_section_contains_FOUR_ questionsJEE1_This_section_contains_FOUR_ questions
JEE1_This_section_contains_FOUR_ questions
 

The dynamics of drug ABSORPTION and DISTRIBUTION

  • 1. The dynamics of drug absorption and distribution Presented by : Tailor Himani Rajubhai Department of Pharmacology L. M. College Of Pharmacy
  • 2. Physicochemical factors in transfer of drugs across membranes: • The determining characteristics of the drug are its molecular size and shape, degree of ionization, relative lipid solubility of its ionized and unionized forms, and its binding to tissue proteins. • Despite of structural differences the diffusion and transport of drugs across these various boundaries have many common characteristics, since drugs in general pass through cells rather than between them. The plasma membrane thus represents the common barrier. • Drug molecules can cross cell membrane by: passive diffusion; protein-mediated transport ( facilitated and active transport)
  • 3. Biological Membrane • Bilayer of amphipathic lipid  hydrocarbon chains oriented inward to form a continues hydrophilic tail and hydrophilic head oriented outward. • Membrane proteins embedded in the bilayer serve as receptors, ion channel or transporters to elicit electrical or chemical signaling pathways and provide selective targets for drug action. -
  • 4. Passage of drug across cell membrane • The cell membrane acts as a biological barrier. The following are the processes by which a drug can cross biological membrane 1. Passive transport -Diffusion(simple) -Filtration -osmosis 2. Specialized transport -Active transport *Primary active transport(direct active transport) *secondary active transport(co-transport)
  • 6. A. Passive membrane transport • This transport is energy independent and no utilization of ATPs. a. Diffusion (simple) • Diffusion is the net movement of drug molecules from an area of high concentration to an area with lower concentration. • The difference of concentration between the two areas is termed as the concentration gradient, and diffusion will continue until this gradient has been eliminated. • Diffusion across the cell membrane depends on concentration gradient and lipid solubility. Lipid solubility depends on ionization. Un-ionized drugs are more lipid soluble and are better absorbed (more reabsorbed in the kidneys and less excreted). • Ionized drugs are less lipid soluble and are less absorbed (less reabsorbed in kidneys and more excreted). Ionization depends on pH of drug and pH of the medium (surrounding fluid). • If the pH is the same the drug remain unionized and become more lipid soluble and absorbed better. Acidic drugs like aspirin, barbiturates, etc. are better absorbed from the stomach. Alkaline drugs like morphine, atropine, and chloroquine are better absorbed from the small intestine. If pH is opposite-> drug is ionized-> less lipid soluble-> less absorption (e.g. alkaline drugs are poorly absorbed in the stomach). .
  • 7. b. Filtration and Osmosis • This can be accelerated if hydrodynamic flow of the solvent is occurring under hydrostatic or osmotic pressure gradient. E.g: across most capillaries including glomeruli. Filtration- is movement of drugs through aqueous pores in the membrane or through paracellular spaces. • Lipid insoluble drugs can cross the biological membrane by filtration if the molecular size is smaller than that of the diameter of pores. Osmosis-Osmosis is the movement of water molecule through the cell membrane (semi permeable membrane) from the region of higher water concentration to the region of less water concentration is called osmosis
  • 8.
  • 9. Weak electrolytes and influence of pH • Most drugs are- weak acids or bases. • Non-ionized molecules- lipid soluble- diffuse across membrane. • Transmembrane distribution of weak electrolyte is usually determined by its pKa and pH gradient. pKa is numerically equal to the pH at which the drug is 50% ionized. • Henderson- hasselbalch equation: for weak acid, • pH= pKa+ log [A-]/ [HA] where, A- is ionized and HA is unionized drug. If concentration of both is equal then log 1= 0 hence pH= pKa. • If pH is increased by scale 1 scale then log [A-]/ [HA] =1 or [A-]/ [HA] =10. Similarly if reduced by 1 then [A-]/ [HA] = 1/10.
  • 11. a. Facilitated diffusion(solute carrier SLC transporters)-It is the movement of drug molecules across the cell membrane via special transport proteins that are present within the cellular membrane. • Many large molecules, such as glucose, are insoluble in lipids and too large to pass through the membrane pores. Therefore, it will bind with its specific carrier proteins, and moved through the cellular membrane.
  • 12. • Active transport- In active transport, the drug molecule penetrates in the lipid bilayer membrane from lower concentration to the higher concentration of solutes against the concentration gradient by utilizing energy (ATP) and with the help of carrier proteins. • There are two types - Primary active transport and -secondary active transport.
  • 14. Absorption • Absorption is the movement or transfer of a drug from it’s site of application into the blood circulation. • Not only the fraction of administered dose that gets absorbed, but also the rate of absorption is important • When a drug is administered intravenously, absorption is not required because the drug is transferred from the administration device directly into the bloodstream. In the case of intravenous administration, the entire dose of the drug is available to move to the sites of drug action. • Drug administration by other routes may result in only partial absorption and thus, lower bioavailability. • Passage of drug across cell membrane- The cell membrane acts as a biological barrier.
  • 15. Factors affecting absorption 1. Lipid solubility- Absorption of drugs depends on lipid solubility. Absorption is more if the drug is lipid soluble. Lipid solubility depends on ionization. Un-ionized drugs are more lipid soluble and are better absorbed. Ionized drugs are less lipid soluble and are less absorbed. 2. Molecular size- Smaller the molecular size of the drug rapid is the absorption. 3. Particle size - Particle may be composed either of a single molecule or more than hundred molecules. Larger is the particle size, slower will be the diffusion and absorption and vice versa.
  • 16. 4. Degree of ionization- Un-ionized drugs are more lipid soluble and are better absorbed (more reabsorbed in the kidneys and less excreted). Ionized drugs are less lipid soluble and are less absorbed (less reabsorbed in kidneys and more excreted). Ionization depends on pH of drug and pH of the medium (surrounding fluid). If the pH is the same the drug remain unionized and become lipid soluble and absorbed better. (e.g. acidic drugs like aspirin, barbiturates, etc. are better absorbed from the stomach. Weakly alkaline drugs like morphine, atropine, chloroquine are better absorbed from the small intestine. 5. Physical forms- Drugs may exist as solids, liquids or gases. Gases are rapidly absorbed than the liquids, while liquids are rapidly absorbed than the solids. Thus the drugs in syrup or suspension form are rapidly absorbed than the tablets or capsules. Volatile general anaesthetics absorbed rapidly through the pulmonary route. .
  • 17. 6. Chemical nature-Chemical nature is responsible for the selection of the route of drug administration. Examples- Heparin is a drug with large molecular weight, and is cannot be given orally, insulin is degraded if given orally, benzyl penicillin also get degraded if given orally. Hence these drugs should be administered parenterally to avoid the inactivation 7. Dosage forms- Dosage forms affect the rate and extent of absorption. Example – nitroglycerin when given by sublingual route disintegrates rapidly but stays for a shorter duration. When it is given orally, it disintegrates slowly and stays for longer duration. 8. Concentration - If the drug concentration increases the drug absorption across the cell membrane also increases. 9. Area of absorptive surface- Most of the drugs are given orally because of the large area of absorptive surface, so that greater absorption occurs. Organophosphate compounds (insecticides) are highly lipid soluble and poisoning can occur even by absorption through skin.
  • 18. 10.Vascularity - If the vascularity (blood supply) is more, the drug absorption also increases. In shock, the blood supply decreases, hence the drug absorption decreases. During IM inj massage increases vascular supply and drug absorption 11. pH – Acidic pH favours the absorption of acidic drugs and basic pH favours the absorption of basic drugs. 12. Presence of other substances- Food can increase or decrease the drug absorption. Examples- Atorvastatin is better absorbed when taken with the food. Milk decreases the absorption of iron. Vitamin C enhances the absorption of iron. Milk decreases the absorption of tetracycline. 13. GI motility- The drug absorption gets altered in diarrhoea or constipation. 14-Diseases- In diarrhoea drug absorption decreases, malabsorptive syndrome- decreases drug absorption, in achlorhydria – decreases the absorption of acidic drugs.
  • 19. DRUG DISTRIBUTION • Once in the blood, drugs are simultaneously distributed throughout the body and eliminated. Typically, distribution is much more rapid than elimination, is accomplished via the circulation, and is influenced by regional blood flow. Volume of Distribution (Vd) Definition: Apparent Volume of distribution is defined as the volume that would accommodate all the drugs in the body, if the concentration was the same as in plasma, Expressed as: in Liters Vd = Dose administered IV Plasma concentration
  • 20. A. Compartments 1. Central Compartment • The central compartment includes the well-perfused organs and tissues • (heart, blood, liver, brain and kidney) with which drug equilibrates rapidly.
  • 21. 2. Peripheral Compartment(s) • The peripheral compartment(s) include(s) those organs (e.g., adipose and skeletal muscle) which are less well-perfused, and with which drug therefore equilibrates more slowly. • Redistribution from one compartment to another often alters the duration of effect at the target tissue. • For example, thiopental, a highly lipid-soluble drug, induces anaesthesia within seconds because of rapid equilibration between blood and brain. • Despite the fact that the drug is slowly metabolized, however, the duration of anesthesia is short because of drug redistribution into adipose tissue, which can act as a storage site, or drug reservoir.
  • 22. 3. Special compartment • Several special compartments deserve mention. • Entry of drug into the cerebrospinal fluid (CSF) and central nervous system (CNS) is restricted by the structure of the capillaries and pericapillary glial cells (the choroid plexus is an exception). • The blood-brain barrier limits the success of antibiotics, anticancer drugs and other agents used to treat CNS diseases. • Drugs also have relatively poor access to pericardial fluid, bronchial secretions and fluid in the middle ear, thus making the treatment of infections in these regions difficult.
  • 23.
  • 24. B. Protein Binding • Many drugs bind to plasma proteins. Weak acids and neutral drugs bind particularly to albumin, while basic drugs tend to bind to alpha-1-acid glycoprotein (orosomucoid).
  • 25. Effects on drug distribution • Only that fraction of the plasma drug concentration which is freely circulating (i.e., unbound) can penetrate cell membranes. • Protein binding thus decreases the net transfer of drug across membranes. • Drug binding to plasma proteins is generally weak and rapidly reversible, however, so that protein-bound drug can be considered to be in a temporary storage compartment. • The protein concentration of extravascular fluids (e.g., CSF, lymph, synovial fluid) is very low. • The extent of protein binding must be considered in interpreting "blood levels" of drugs.
  • 26. Placental Transfer of Drugs • The transfer of drugs across the placenta is of critical importance because drugs may cause anomalies in the developing fetus. • Administered immediately before delivery, as is often the case with the use of tocolytics in the treatment of preterm labor, they also may have adverse effects on the neonate. • As in the brain, P-gp and other export transporters are present in the placenta and function to limit fetal exposure to potentially toxic agents.
  • 27. References: • http://downloads.lww.com/wolterskluwer_vitalstream_com/sample- content/9780781773485_Sakai/samples/Sakai_Ch03.pdf • “The pharmacological basis of therapeutics “by Goodman & Gilman, tenth edition. • “Essential of medical pharmacology” by KD Tripathi, seventh edition.